Sophie Valkenburg and her team have been awarded with a special grant to conduct research on SARS-CoV-2 following a call from the Health and Medical Research Fund (HMRF).
Those funds will allow the team to work on a crucial project : assessing novel coronaviruses antibodies for specificity and function during clinical infection and community asymptomatic cases. Sophie Valkenburg's team published earlier a major paper on SARS-CoV-2 called Beyond the Spike: identification of viral targets of the antibody response to SARS-CoV-2 in COVID-19 patients.
The HMRF is going to support 26 research studies on COVID-19 under its commissioned research programme which cover a wide range of topics to address important research areas in transmissibility and infectability of the virus, effective detection and surveillance and prevention strategies of the disease and development of treatments and therapies.
